Počet záznamov: 1
tachykiníny
SYS d015320 LBL 00000nz--a2200000o--4500 005 20250606212934.9 008 920531|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 065 $a D12.644.276.812.900 065 $a D12.644.400.800 065 $a D12.644.456.800 065 $a D12.776.467.812.900 065 $a D12.776.631.650.800 065 $a D23.469.050.375.850 065 $a D23.529.812.900 066 $a 01 $c 03 150 $a tachykiníny $x AD $x AE $x AG $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x DE $x DF $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 550 $7 sllk_us_auth*d018377 $Y Neurotransmitter Agents $w P $a látky neurotransmiterové 550 $7 sllk_us_auth*d018039 $Y Receptors, Tachykinin $w p $a receptory tachykinínové 665 $a 89; PHYSALAEMIN was see under KININS 1977-88 $2 eng 665 $a Kinins (1966-1988) $2 eng 665 $a Nerve Tissue Proteins (1966-1988) $2 eng 665 $a Neuropeptides (1987-1988) $2 eng 665 $a Oligopeptides (1966-1988) $2 eng 665 $a Peptides (1966-1988) $2 eng 680 9-
$i A family of biologically active peptides sharing a common conserved C-terminal sequence, -Phe-X-Gly-Leu-Met-NH2, where X is either an aromatic or a branched aliphatic amino acid. Members of this family have been found in mammals, amphibians, and mollusks. Tachykinins have diverse pharmacological actions in the central nervous system and the cardiovascular, genitourinary, respiratory, and gastrointestinal systems, as well as in glandular tissues. This diversity of activity is due to the existence of three or more subtypes of tachykinin receptors. $2 eng 680 $a general or unspecified; prefer specifics $2 eng 750 -2
$a Tachykinins $2 eng 980 $x M
Počet záznamov: 1